Journey Medical Corp (DERM)
Journey Medical stock today
Journey Medical closed at $5.17 on October 30, 2026, down 4.44% on the day. Over the past year it returned -37.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $142 million.
| Period | DERM | S&P 500 (SPY) |
|---|---|---|
| 1 month | -24.4% | -0.9% |
| 3 months | -19.8% | +2.1% |
| Year to date | -32.9% | +11.7% |
| 1 year | -37.8% | +12.4% |
| 3 years | +61.6% | +88.5% |
Key statistics
- Market value
- $142M
- Forward P/E
- 32.7
- Price / sales
- 2.1
- 52-week range
- $4.39 to $9.26
- Next report
- Nov 11, 2026 (estimated)
About Journey Medical
Develops and commercializes topical dermatology and specialty pharmaceutical products.
Sector: Health Care
More on Journey Medical
- Financials: revenue, earnings and segmentsRevenue +10% in the year to Dec 2025
- Returns: what $1,000 became$1,000 three years ago is $1,616 today
No forecast, no recommendation. This page describes Journey Medical Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.